| 000 | 01723 a2200517 4500 | ||
|---|---|---|---|
| 005 | 20250513234750.0 | ||
| 264 | 0 | _c20010802 | |
| 008 | 200108s 0 0 eng d | ||
| 022 | _a0278-5846 | ||
| 024 | 7 |
_a10.1016/s0278-5846(00)00164-0 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aCesková, E | |
| 245 | 0 | 0 |
_aThe changes of biological markers and treatment efficacy in schizophrenia. _h[electronic resource] |
| 260 |
_bProgress in neuro-psychopharmacology & biological psychiatry _cFeb 2001 |
||
| 300 |
_a323-35 p. _bdigital |
||
| 500 | _aPublication Type: Comparative Study; Journal Article | ||
| 650 | 0 | 4 | _aAcute Disease |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAmisulpride |
| 650 | 0 | 4 |
_aAntipsychotic Agents _xtherapeutic use |
| 650 | 0 | 4 |
_aBiomarkers _xblood |
| 650 | 0 | 4 |
_aBrain _xdiagnostic imaging |
| 650 | 0 | 4 | _aCognition |
| 650 | 0 | 4 | _aDexamethasone |
| 650 | 0 | 4 | _aFollow-Up Studies |
| 650 | 0 | 4 |
_aHaloperidol _xtherapeutic use |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aHydrocortisone _xblood |
| 650 | 0 | 4 | _aInpatients |
| 650 | 0 | 4 | _aMemory |
| 650 | 0 | 4 |
_aPerphenazine _xtherapeutic use |
| 650 | 0 | 4 | _aPsychological Tests |
| 650 | 0 | 4 | _aPsychomotor Performance |
| 650 | 0 | 4 | _aReaction Time |
| 650 | 0 | 4 |
_aSchizophrenia _xblood |
| 650 | 0 | 4 | _aSchizophrenic Psychology |
| 650 | 0 | 4 |
_aSulpiride _xanalogs & derivatives |
| 650 | 0 | 4 | _aTime Factors |
| 650 | 0 | 4 | _aTomography, X-Ray Computed |
| 700 | 1 | _aDrybcák, P | |
| 700 | 1 | _aHrobar, P | |
| 700 | 1 | _aLorenc, M | |
| 700 | 1 | _aSpacek, J | |
| 773 | 0 |
_tProgress in neuro-psychopharmacology & biological psychiatry _gvol. 25 _gno. 2 _gp. 323-35 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/s0278-5846(00)00164-0 _zAvailable from publisher's website |
| 999 |
_c11229653 _d11229653 |
||